Outcomes of cataract surgery in patient with wet age-related macular degeneration while being treated with intravitreal Aflibercept with treat-and-extend regimen

被引:0
|
作者
Nagai, Tatsuya [1 ]
Nizawa, Tomohiro [1 ]
Kitahashi, Masayasu [1 ]
Baba, Takayuki [1 ]
Yamamoto, Shuichi [1 ]
Iwase, Takehito [1 ]
机构
[1] Chiba Univ Hosp, Chiba, Japan
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
88
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Two-Year Outcomes of a Treat-and-Extend Regimen Using Intravitreal Aflibercept Injections for Typical Age-Related Macular Degeneration
    Ito, Arisa
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Akiyama, Hideo
    [J]. OPHTHALMOLOGICA, 2017, 238 (04) : 236 - 242
  • [2] One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration
    Yamamoto, Akiko
    Okada, Annabelle A.
    Nakayama, Makiko
    Yoshida, Yumiko
    Kobayashi, Hiroaki
    [J]. OPHTHALMOLOGICA, 2017, 237 (03) : 139 - 144
  • [3] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Mohamed Kamel Soliman
    Nicolas Tuli
    Thomas K. Lee
    William A. Britton
    Raman Tuli
    [J]. International Journal of Retina and Vitreous, 7
  • [4] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    [J]. OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
  • [5] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Soliman, Mohamed Kamel
    Tuli, Nicolas
    Lee, Thomas K.
    Britton, William A.
    Tuli, Raman
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [6] Comparison of two different treat-and-extend protocols with aflibercept in wet age-related macular degeneration
    Taipale, Claudia
    Lindholm, Juha-Matti
    Laine, Ilkka
    Tuuminen, Raimo
    [J]. ACTA OPHTHALMOLOGICA, 2020, 98 (03) : 267 - 273
  • [7] A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
    Kikushima, Wataru
    Sakurada, Yoichi
    Fukuda, Yoshiko
    Matsubara, Mio
    Kotoda, Yumi
    Sugiyama, Atsushi
    Kashiwagi, Kenji
    [J]. PHARMACEUTICALS, 2023, 16 (04)
  • [8] Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration A Prospective Study
    Maruko, Ichiro
    Ogasawara, Masashi
    Yamamoto, Akiko
    Itagaki, Kanako
    Hasegawa, Taiji
    Arakawa, Hisaya
    Nakayama, Makiko
    Koizumi, Hideki
    Okada, Annabelle A.
    Sekiryu, Tetsuju
    Iida, Tomohiro
    [J]. OPHTHALMOLOGY RETINA, 2020, 4 (08): : 767 - 776
  • [9] Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients
    Ishibashi, Koki
    Haruta, Masatoshi
    Ishibashi, Yumi
    Noda, Rie
    Dake, Shotaro
    Yoshida, Shigeo
    [J]. THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [10] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192